Q3 2025 Talphera Inc Earnings Call Transcript

Nov 12, 2025 / 09:30 PM GMT

Release Date Price: €1.09 (+1.67%)

Transcript 10-Q8-K

Key Points

Positve

Talphera Inc (TLPH) successfully completed the first closing of a $17 million two-tranche financing, providing sufficient capital for planned approval of the NAIAD PMA.
Strategic investment from Cremedics includes a $5 million minority investment and a 60-day exclusive negotiation period for a potential acquisition.
Existing and new institutional investors committed an additional $12 million in a second tranche, contingent on achieving the NFR study primary endpoint.
Restructuring of the nephro clinical study led to accelerated enrollment rates, with new target profile institutions showing promising enrollment speed.
Talphera Inc (TLPH) has a clear regulatory path with FDA breakthrough designation, minimizing regulatory risk and ensuring efficient agency access.

Negative

Delays in activating new clinical sites have pushed the estimated completion of the nephro study to the first half of 2026.
Only 2 out of the 6 new target profile sites have been activated, with the remaining sites facing unique institutional delays.
Enrollment rates at new target sites have not significantly increased despite initial expectations.
Federal government volatility and funding issues have affected some institutions, contributing to delays in study activation.
The Veterans Affairs Medical Center faced personnel cuts, adding 3 to 4 months to their timeline for site activation.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

TLPH.OQ - Talphera Inc
Q3 2025 Talphera Inc Earnings Call
Nov 12, 2025 / 09:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome to the Tolfera 3rd quarter 2025 financial results conference call. This call is being webcast live via the events page of the investors section of Tolfera's website at www.Telfera.com.

You may listen to a replay of this webcast by going to the investors section of Telfera's website. I would now like to turn the call over to Rafi Essadorian, Telfera's Chief Financial Officer. Please go ahead.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you for joining us on the call today. Today, we announced our 3rd quarter 2025 financial results and associated business updates in a

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.